Erratum: Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma

Wenting Pan, Jinyun Yang, Jinyu Wei, Hongwei Chen, Yunxia Ge, Jingfeng Zhang, Zhiqiong Wang, Changchun Zhou, Qipeng Yuan, Liqing Zhou, Ming–Hsuan YangScientific 2015 · DOI · OpenAlex

Abstract

B-cell lymphoma-2 (BCL-2) is a critical regulator of apoptosis, and its overexpression is a known driver of cancer cell survival. This study investigates the association between three functional BCL-2 genetic polymorphisms (rs2279115, rs1801018, and rs1564483) and the risk of esophageal squamous cell carcinoma (ESCC). Through a large-scale case-control study in Chinese populations and subsequent functional validation, researchers identified a significant protective effect associated with the rs2279115 AA genotype, which correlates with reduced BCL-2 expression.

Introduction

Esophageal squamous cell carcinoma (ESCC) remains a significant global health challenge, characterized by high aggression and a complex interplay of genetic and environmental risk factors. A fundamental mechanism in oncogenesis is the evasion of programmed cell death, or apoptosis. The BCL-2 gene produces a pro-survival protein that inhibits apoptosis; consequently, genetic variations that lead to its upregulation can facilitate the survival of damaged cells, promoting tumor development.

This research, originally published in Scientific Reports, addresses how common Single Nucleotide Polymorphisms (SNPs) within the regulatory regions of BCL-2 influence ESCC susceptibility. While a recent erratum was issued to correct author institutional affiliations, the core scientific findings regarding the genetic underpinnings of the disease remain robust and insightful.

Methodology

The researchers conducted a candidate-gene association study followed by functional validation in two independent cohorts from China.

Study Population and Genotyping

The study included a total of 3,188 participants, comprising 1,588 ESCC patients and 1,600 cancer-free controls. Three specific polymorphisms—rs2279115, rs1801018, and rs1564483—were genotyped to determine their frequency in both groups.

Statistical and Functional Analysis

Logistic regression was utilized to calculate Odds Ratios (ORs) and 95% Confidence Intervals (CIs), adjusting for confounding factors such as age and sex. To establish a biological link between genotype and phenotype, the team analyzed BCL-2 mRNA expression levels in both normal and cancerous esophageal tissues across different genotypes.

Results and Discussion

Genetic Association with ESCC Risk

The primary finding was a significant association between the rs2279115 polymorphism and ESCC risk. Individuals with the AA genotype exhibited a significantly lower risk compared to those with the CC genotype (OR = 0.72, 95% CI = 0.57–0.90, P = 0.005). This suggests that the "A" allele serves a protective function, providing a roughly 28% reduction in risk compared to the CC genotype.

Gene-Environment Interactions

The protective effect of the rs2279115 AA genotype was notably amplified in specific subgroups:

  • Non-smokers: OR = 0.42 (95% CI = 0.29–0.59, P = 0.001)
  • Non-drinkers: OR = 0.44 (95% CI = 0.32–0.62, P = 0.002)

These results indicate that while genetic factors are influential, heavy environmental insults like tobacco and alcohol consumption may "override" or mask the inherent protection provided by certain genetic variants.

Functional Impact on BCL-2 Expression

Genotype-phenotype correlation studies provided a mechanistic explanation for the observed risk reduction. Subjects carrying the protective AA or CA genotypes showed a statistically significant decrease in BCL-2 mRNA expression in both healthy and tumorous esophageal tissues compared to those with the CC genotype. Lower expression of this anti-apoptotic protein likely facilitates the clearance of cells with oncogenic mutations, thereby reducing the likelihood of tumor formation.

Conclusion

This study identifies the BCL-2 rs2279115 polymorphism as a significant contributor to ESCC susceptibility in Chinese populations. The findings highlight the importance of regulatory genetic variants in cancer etiology and suggest that the protective "AA" genotype operates by modulating BCL-2 expression levels. While these results are compelling, further research is required to validate these findings in diverse ethnic groups and to explore the broader apoptotic pathway interactions through protein-level validation and comprehensive pathway analysis.

Summary updated

Abstract

B-cell lymphoma-2 (BCL-2) prevents apoptosis and its overexpression could promote cancer cell survival. Multiple functional BCL-2 genetic polymorphisms, such as rs2279115, rs1801018 and rs1564483, have been identified previously and might be involved in cancer development through deregulating BCL-2 expression. Therefore, we examined associations between these three polymorphisms and esophageal squamous cell carcinoma (ESCC) susceptibility as well as its biological function in vivo . Genotypes were determined in two independent case-control sets consisted of 1588 ESCC patients and 1600 controls from two regions of China. Odds ratios ( ORs ) and 95% confidence intervals ( CIs ) were calculated by logistic regression. The impact of the rs2279115 polymorphism on BCL-2 expression was detected using esophagus tissues. Our results demonstrated that the BCL-2 rs2279115 AA genotype was significantly associated with decreased ESCC risk compared with the CC genotype ( OR = 0.72, 95% CI = 0.57–0.90, P = 0.005), especially in nonsmokers ( OR = 0.42, 95% CI = 0.29–0.59, P = 0.001) or nondrinkers ( OR = 0.44, 95% CI = 0.32–0.62, P = 0.002). Genotype-phenotype correlation studies demonstrated that subjects with the rs2279115 CA and AA genotypes had a statistically significant decrease of BCL-2 mRNA expression compared to the CC genotype in both normal and cancerous esophagus tissues. Our results indicate that the BCL-2 rs2279115 polymorphism contributes to ESCC susceptibility in Chinese populations.
BibTeX
@inproceedings{pan2015erratum,
  author = {Wenting Pan and Jinyun Yang and Jinyu Wei and Hongwei Chen and Yunxia Ge and Jingfeng Zhang and Zhiqiong Wang and Changchun Zhou and Qipeng Yuan and Liqing Zhou and Ming–Hsuan Yang},
  title = {{Erratum: Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma}},
  booktitle = {Scientific},
  year = {2015},
  doi = {10.1038/srep14020},
}

Loading related content...

Figure